Navigation Links
Strativa Pharmaceuticals Provides Product Pipeline Update
Date:4/9/2009

Files NDA for Ondansetron Orally Dissolving Film Strip

BioAlliance to Resubmit Loramyc(R) NDA

WOODCLIFF LAKE, N.J., April 9 /PRNewswire-FirstCall/ -- Strativa Pharmaceuticals, the proprietary products division of a wholly owned subsidiary of Par Pharmaceutical Companies, Inc. (NYSE: PRX), today provides an update on two of its pipeline products.

Ondansetron Orally Dissolving Film Strip

On April 7, 2009, Strativa submitted a New Drug Application (NDA) for its new orally dissolving film strips (ODFS) formulation of ondansetron to the U.S. Food and Drug Administration (FDA). Strativa is seeking approval of ondansetron ODFS in 8 mg and 4 mg strengths for the prevention of chemotherapy and radiation-induced nausea and vomiting, and prevention of post-operative nausea and vomiting.

A program consisting of three separate pivotal studies comparing the bioequivalence of ondansetron ODFS 8mg to Zofran ODT(R) 8mg was completed in December 2008 and supports the NDA filing of ondansetron ODFS. The pharmacokinetic results of each study demonstrate that a single dose of ondansetron ODFS, taken with or without water, is bioequivalent to Zofran ODT, taken under similar conditions.

The antiemetic market totaled 4.1 million prescriptions in 2008. Ondansetron was the prescription leader in the category, accounting for 95% of prescriptions.

In June 2008, Strativa acquired the commercialization rights in the United States and its territories to ondansetron ODFS from MonoSol Rx. To date, Strativa has paid MonoSol Rx a total of $3.5 million for the completion of certain milestones.

Loramyc(R) (miconazole Lauriad) for the treatment of oropharyngeal candidiasis (OPC)

After preliminary review, the FDA h
'/>"/>

SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Strativa Pharmaceuticals Announces Phase III Results for Loramyc(R) to Treat Oropharyngeal Candidiasis
2. Strativa Pharmaceuticals Announces Preliminary Results from ONCONASE(R) Phase IIIb Clinical Trial
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
9. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
10. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
11. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... As health officials across the Midwest warn against the widespread ... Michigan will offer free diagnostic testing for ... to administer tests and, in some cases, fill the matching ... the study. The Grand Rapids, Mich. ...
(Date:1/15/2014)... , Jan. 15, 2014 Massachusetts General ... AMGN ) announced today that they ... and validate new therapeutic targets and develop novel ... disorder that affects millions worldwide. The MGH-Broad-Amgen collaboration ...
(Date:1/15/2014)... , Jan. 15, 2014  Manufacturers, suppliers and ... be able to protect their most important business ... http://photos.prnewswire.com/prnh/20130716/CL46586LOGO ) Because of the ... steadfastly remains one of the most litigious industry ...
Breaking Medicine Technology:Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Intellectual Property Insurance for Medical-related Products and Services 2
... CHARLOTTESVILLE, Va. , May 28 The Focused Ultrasound Surgery ... the 2nd International Symposium on MR-guided Focused Ultrasound and can be accessed ... , , ... near Dulles International Airport, Washington, DC , the symposium ...
... ProUroCare Medical, Inc. (OTC Bulletin Board: PUMD, PUMDU and PUMDW), ... will be attending the American Urological Association (AUA) 2010 Annual ... – June 1 . At the conference, the ... to educate urologists about the concept and potential of elasticity ...
Cached Medicine Technology:Abstract Submissions and Registration Now Open for 2nd International Symposium on MR-Guided Focused Ultrasound 2Abstract Submissions and Registration Now Open for 2nd International Symposium on MR-Guided Focused Ultrasound 3ProUroCare to Showcase Investigational Portable Platform for Its Prostate Imaging Device at AUA 2010 2
(Date:4/17/2014)... non-cancerous prostate tissue may have nearly twice the risk ... inflammation, according to results of a new study led ... , The link between persistent inflammation and cancer was ... those with a Gleason score between 7 and ... and rapidly growing prostate cancers. , "What we,ve shown ...
(Date:4/17/2014)... most popular vaccine brands for children may not be ... some cost factors when choosing vaccines, driving the market ... to a new study by University of Illinois researchers. ... driven by numerous factors," says Sheldon H. Jacobson, a ... science and of mathematics at the U. of I. ...
(Date:4/17/2014)... of California, San Diego School of Medicine report that ... a recent major loss are more likely to be ... study is published in this month,s issue of the ... compassionate behaviors are associated with better health and well-being ... ways to improve the outcomes of individuals whose deficits ...
(Date:4/17/2014)... Hospital Pediatrician-in-Chief Jon McCullers, MD, was recently invited ... of Nature Reviews Microbiology , one of ... a world-renowned infectious disease specialist, and chair of ... Tennessee Health Science Center, analyzed the epidemiology and ... 1968 pandemics, as well as more recent 2009 ...
(Date:4/17/2014)... 2014) Doctors who treat patients with a ... can face an agonizing treatment decision. , The ... and help relieve shortness of breath. But some ... can cause potentially fatal complications following transplantation. , ... Dilling, medical director of Loyola University Medical Center,s ...
Breaking Medicine News(10 mins):Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Study recalculates costs of combination vaccines 2Health News:The ilk of human kindness 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3
... - Avoid Select Vitamins, Try Acupuncture, NORTHBROOK, ... American College of Chest Physicians (ACCP) recommend,against the ... general,screening of lung cancer. Published as a supplement ... of the ACCP, the guidelines cite there,is little ...
... Ohio, Sept. 10 AtriCure, Inc.,(Nasdaq: ATRC ... and selling innovative cardiac surgical devices, announced,today that ... implanted during an open-heart surgical procedure performed by,Professor ... University of Zurich,in Switzerland with the support of ...
... think they have a vaginal yeast infection are wrong ... treating their problem, says a Saint Louis University researcher ... isnt a yeast infection, said Susan Hoffstetter, Ph.D., assistant ... Louis University School of Medicine and a SLUCare womens ...
... Sept. 10 Sangamo,BioSciences, Inc. (Nasdaq: SGMO ) ... officer, will provide an update on,the progress of Sangamo,s ... business strategy at 1:30 pm (PT) on Monday,September 17, ... San Francisco. The presentation will be webcast live ...
... A vascular surgery technique pioneered at UT Southwestern ... thigh to repair the aorta does not create blood-flow ... patients, researchers report. , Vascular disease is a major ... of the aorta. Inserting synthetic grafts to repair damaged ...
... could fight cancer, heart disease, researchers say , , MONDAY, Sept. ... life, a new European study suggests. , "The intake ... from any cause of death," said lead researcher Dr. Philippe ... Lyon, France. , The new finding, published in the Sept. ...
Cached Medicine News:Health News:New Lung Cancer Guidelines Oppose General CT Screening 2Health News:New Lung Cancer Guidelines Oppose General CT Screening 3Health News:New Lung Cancer Guidelines Oppose General CT Screening 4Health News:AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System 2Health News:AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System 3Health News:AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System 4Health News:Common misdiagnosis: most women believe they have a yeast infection when they don't 2Health News:Sangamo BioSciences to Present at the ThinkEquity Partners Growth Conference 2Health News:Natural aorta grafts have few side effects for infection-prone patients 2Health News:Vitamin D Supplements May Lengthen Life 2
Fechtner Trabeculectomy Marker...
... Accurately tests for Nystagmus when rotated ... high by 8" diameter. Light weight ... bearings for effortless spin mechanism. For ... patient. Includes both Adult and Pediatric ...
Sterile squares of smooth foil for repair of the floor of the orbit and other plastic surgery. Available in large size....
Segment stand magnifiers come complete with bar magnifier to achieve a higher magnification while still maintaining a wide binocular field of view....
Medicine Products: